EA202192117A1 - Способ лечения множественной миеломы - Google Patents
Способ лечения множественной миеломыInfo
- Publication number
- EA202192117A1 EA202192117A1 EA202192117A EA202192117A EA202192117A1 EA 202192117 A1 EA202192117 A1 EA 202192117A1 EA 202192117 A EA202192117 A EA 202192117A EA 202192117 A EA202192117 A EA 202192117A EA 202192117 A1 EA202192117 A1 EA 202192117A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- multiple myeloma
- subject
- treatment
- administering
- molecular weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Один аспект, описанный в настоящем документе, включает в себя способ лечения множественной миеломы (ММ) у субъекта, нуждающегося в нем, содержащий введение субъекту эффективного количества низкомолекулярного соединения. Более конкретно, другой аспект, описанный в настоящем документе, включает в себя способ лечения множественной миеломы у субъекта, нуждающегося в нем, содержащий введение субъекту эффективного количества низкомолекулярного соединения, описанного в настоящем документе, в сочетании с химиотерапевтическим агентом.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962812002P | 2019-02-28 | 2019-02-28 | |
PCT/US2020/019884 WO2020176610A1 (en) | 2019-02-28 | 2020-02-26 | Method for treating a multiple myeloma |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202192117A1 true EA202192117A1 (ru) | 2021-11-23 |
Family
ID=72238680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202192117A EA202192117A1 (ru) | 2019-02-28 | 2020-02-26 | Способ лечения множественной миеломы |
Country Status (11)
Country | Link |
---|---|
US (1) | US20220143016A1 (ru) |
EP (1) | EP3931196A4 (ru) |
JP (1) | JP2022521801A (ru) |
CN (1) | CN113710670A (ru) |
AU (1) | AU2020227748A1 (ru) |
BR (1) | BR112021016747A2 (ru) |
CA (1) | CA3131249A1 (ru) |
EA (1) | EA202192117A1 (ru) |
IL (1) | IL285800A (ru) |
MX (1) | MX2021010398A (ru) |
WO (1) | WO2020176610A1 (ru) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH593266A5 (ru) * | 1973-09-20 | 1977-11-30 | Delalande Sa | |
AU2002228922A1 (en) * | 2000-12-12 | 2002-06-24 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
CA2813003A1 (en) * | 2010-10-05 | 2012-04-12 | Fresenius Kabi Usa, Llc | Bortezomib formulations stabilised with boric acid |
PE20151413A1 (es) * | 2012-11-21 | 2015-10-23 | Ptc Therapeutics Inc | Inhibidores de bmi-1 de pirimidina inversa sustituida |
JP2021535198A (ja) * | 2018-08-17 | 2021-12-16 | ピーティーシー セラピューティクス, インコーポレイテッド | 膵臓癌を治療する方法 |
EP3938368B1 (en) * | 2019-03-11 | 2023-06-07 | PTC Therapeutics, Inc. | Compound form having enhanced bioavailability and formulations thereof |
-
2020
- 2020-02-26 WO PCT/US2020/019884 patent/WO2020176610A1/en unknown
- 2020-02-26 JP JP2021550168A patent/JP2022521801A/ja active Pending
- 2020-02-26 BR BR112021016747-1A patent/BR112021016747A2/pt unknown
- 2020-02-26 AU AU2020227748A patent/AU2020227748A1/en active Pending
- 2020-02-26 US US17/433,106 patent/US20220143016A1/en active Pending
- 2020-02-26 CA CA3131249A patent/CA3131249A1/en active Pending
- 2020-02-26 EP EP20762789.4A patent/EP3931196A4/en active Pending
- 2020-02-26 CN CN202080030185.4A patent/CN113710670A/zh active Pending
- 2020-02-26 EA EA202192117A patent/EA202192117A1/ru unknown
- 2020-02-26 MX MX2021010398A patent/MX2021010398A/es unknown
-
2021
- 2021-08-23 IL IL285800A patent/IL285800A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN113710670A (zh) | 2021-11-26 |
EP3931196A4 (en) | 2022-12-14 |
US20220143016A1 (en) | 2022-05-12 |
CA3131249A1 (en) | 2020-09-03 |
AU2020227748A1 (en) | 2021-09-16 |
IL285800A (en) | 2021-10-31 |
EP3931196A1 (en) | 2022-01-05 |
JP2022521801A (ja) | 2022-04-12 |
MX2021010398A (es) | 2022-01-18 |
WO2020176610A1 (en) | 2020-09-03 |
WO2020176610A8 (en) | 2021-08-12 |
BR112021016747A2 (pt) | 2021-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023005160A (es) | Compuestos de 4-aminoisoindolina-1,3-diona sustituidos y su uso para el tratamiento de linfoma. | |
PH12020551244A1 (en) | Pd-1/pd-l1 inhibitors | |
MX2022007968A (es) | Dosificacion de gamma-hidroxibutirato (ghb). | |
EA201890768A3 (ru) | Лечение злокачественной опухоли ингибиторами tor-киназы | |
BR112015013123A2 (pt) | inibidores de beta-lactamase | |
GEP20237519B (en) | Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer | |
EA202190581A1 (ru) | Антисмысловые олигонуклеотиды, нацеленные на scn2a, для лечения энцефалопатии scn1a | |
PH12019500513A1 (en) | Mast cell stabilizers for treatment of hypercytokinemia and viral infection | |
EA202190073A1 (ru) | Композиции и способы лечения видов гемоглобинопатии и талассемии | |
EA202091731A1 (ru) | Ингибиторы аутотаксина и их применения | |
EA201591362A1 (ru) | Соединения и способы лечения бактериальных инфекций | |
MX2013012785A (es) | Tratamiento del mieloma multiple. | |
EA202192122A1 (ru) | Соединения, обладающие активностью индуцирования ферроптоза, и способы их применения | |
MX2022001004A (es) | Inhibidores de enzimas. | |
EA201792287A1 (ru) | Способы лечения рака | |
CL2015002171A1 (es) | Métodos de tratamiento de la dificiencia de hierro con pirofosfato férrico soluble. | |
EA202191170A1 (ru) | Комбинированная терапия для лечения гематологических заболеваний | |
MX2020010697A (es) | Kit, composicion y terapia de combinacion para el sindrome del cromosoma x fragil. | |
ZA202106519B (en) | Caspase inhibitors and methods of use thereof | |
CL2021001922A1 (es) | Procedimientos para tratamiento de enfermedades con inhibidores de magl. | |
EA201690446A1 (ru) | Лечение множественной миеломы | |
MY183483A (en) | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof | |
EA202192117A1 (ru) | Способ лечения множественной миеломы | |
MX2018001684A (es) | Metodo de curacion de heridas. | |
EA202192349A1 (ru) | Комбинации, пригодные в способе лечения саркомы |